Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.0002 | -0.04% | 0.473 | 0.4802 | 0.466 | 0.48 | 0.4732 | 23:59:43 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.435 | 2.49 | 2.06 | 82.53% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 106 | 66,561 | $ 0.4740773 | $ 31,555 | 117,308 | 0.40 - 1.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:40 | 1,094 | $ 0.473 | USD |
Citius Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 13.64M | 28.84M | $ -12.54M | -1.19 | - | 16.53M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 12.00 | 42.70% |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.45 | 0.52 | 0.40 | 0.4403402 | 231,314 | 0.023 | 5.11% |
| 1 Month | 0.5024 | 0.55 | 0.40 | 0.4606027 | 149,822 | -0.0294 | -5.85% |
| 3 Months | 1.00 | 1.0394 | 0.40 | 0.6287139 | 174,858 | -0.527 | -52.7% |
| 6 Months | 1.14 | 1.50 | 0.40 | 0.8153052 | 132,595 | -0.667 | -58.51% |
| 1 Year | 1.24 | 1.90 | 0.40 | 1.01 | 148,169 | -0.767 | -61.85% |
| 3 Years | 3.40 | 5.49 | 0.40 | 1.75 | 114,476 | -2.93 | -86.09% |
| 5 Years | 3.40 | 5.49 | 0.40 | 1.75 | 114,476 | -2.93 | -86.09% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. The company is primarily operating within the critical care and cancer care market segments. |
